Drug intelligence / Profile preview

taraxacum officinale pollen + helianthus annuus pollen + leucanthemum vulgare pollen

Development stage
Approved
Lead developer
Greer Laboratories
Administration
Percutaneous, Intradermal, Subcutaneous
01

Overview

This product is a **combination allergenic extract biologic** composed of non-standardized pollen extracts from *Taraxacum officinale* (dandelion), *Helianthus annuus* (sunflower), and *Leucanthemum vulgare* (daisy). It has been manufactured and distributed by Greer Laboratories and is used in allergy practice for **skin test diagnosis** and **allergen immunotherapy** in patients with clinically relevant sensitization to these pollens. Its pharmacologic effect is immunologic rather than receptor-selective: diagnostically, it is intended to detect allergen-specific immediate hypersensitivity, and therapeutically, repeated exposure is intended to modulate IgE-mediated allergic responses and reduce allergen-induced symptoms in appropriately selected patients. The product was initially approved in the United States in 1968 as part of the allergenic extract category.

Other names
taraxacum officinale pollen + helianthus annuus pollen + leucanthemum vulgare pollendandelion pollen + sunflower pollen + daisy pollentaraxacum officinale + helianthus annuus + leucanthemum vulgare allergenic extract
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on taraxacum officinale pollen + helianthus annuus pollen + leucanthemum vulgare pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on taraxacum officinale pollen + helianthus annuus pollen + leucanthemum vulgare pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call